Screener
TG Therapeutics TGTX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's gross margin?
- TG Therapeutics (TGTX) reported gross margin of 82.4% in Q2 2026.
- How has TG Therapeutics's gross margin changed year-over-year?
- TG Therapeutics's gross margin decreased by 5.3% year-over-year, from 87% to 82.4%.
- What is the long-term trend for TG Therapeutics's gross margin?
- Over 2 years (2023 to 2025), TG Therapeutics's gross margin has grown at a -5.6% compound annual growth rate (CAGR), from 94% to 83.7%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about TG Therapeutics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude